View : 92 Download: 0

Increased serum levels of transforming growth factor-α in patients with colorectal cancer

Title
Increased serum levels of transforming growth factor-α in patients with colorectal cancer
Authors
Shim K.-S.Kim K.-H.Park B.-W.Yi S.-Y.Choi J.-H.Han W.-S.Park E.-B.
Ewha Authors
한운섭박응범김광호이선영
SCOPUS Author ID
한운섭scopusscopus; 박응범scopus; 김광호scopus; 이선영scopus
Issue Date
1998
Journal Title
Diseases of the Colon and Rectum
ISSN
0012-3706JCR Link
Citation
vol. 41, no. 2, pp. 219 - 224
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
PURPOSE: This study was conducted to investigate the serum levels of transforming growth factor-α in patients with colorectal cancer and to investigate the clinical significance of these levels in association with tumor stage and histologic differentiation. Also, serum levels of transforming growth factor-α were measured after curative surgical resection. METHODS: Serum levels of transforming growth factor-α were measured in 42 consecutive patients with colorectal cancer before surgery, in 21 patients after surgical resection (part of the 42 preoperative patients), and in 20 healthy volunteers. We used TGF-α Assay(TM). RESULTS: Serum levels of transforming growth factor-α in patients with colorectal cancer were significantly higher than in the healthy control group (P = 0.001). Significant elevations in serum levels of transforming growth factor-α were found in 50 percent (21/42) of patients with colorectal cancer when the mean + 2 standard deviations (80.4 pg/ml) of the control group were used as the upper limit of the normal range. Serum levels of transforming growth factor- α tended to decrease with increasing tumor size (n = 31; r = -0.52; P = 0.002). Serum levels of transforming growth factor-α before surgery (89.7 ± 44.4 pg/ml; n = 21) significantly decreased to 60.3 ± 19.8 pg/ml after surgical resections of tumors (P = 0.017). Serum levels of transforming growth factor-α completely decreased to the same serum levels of the control group after surgical resections in all patients who had serum levels of transforming growth factor-α greater than mean + 2 standard deviations (80.4 pg/ml) of the control group preoperatively (n = 11; P = 0.002). CONCLUSIONS: Levels of preoperative transforming growth factor-α in patients with colorectal cancer appeared to be higher than levels measured in control subjects. Serum levels of transforming growth factor-a before surgery significantly decreased after surgical resections of tumors. Additional studies are warranted to determine if serum levels of transforming growth factor-α may be useful as a potential biomarker in the management of patients with colorectal cancer.
DOI
10.1007/BF02238252
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE